NCT05748951 is a NA clinical trial of Canalicular occlusion device in Dry Eye, sponsored by AesculaTech, Inc..

Who is sponsoring NCT05748951?

NCT05748951 is sponsored by AesculaTech, Inc..

What drugs are being tested in NCT05748951?

Interventions in NCT05748951: Canalicular occlusion device.

Is NCT05748951 still recruiting?

NCT05748951 is currently completed. Last updated 30 July 2024.

Last reviewed 2024-07-30 · How we verify

NCT05748951

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluating a Device for Blocking the Tear Duct

Completed NA Last updated 30 July 2024

What this trial tests

NA trial testing Canalicular occlusion device in Dry Eye in 33 participants. Completed in 22 February 2024.

Timeline

7 March 2023

Primary endpoint
22 February 2024

22 February 2024

Quick facts

Lead sponsor	AesculaTech, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	33
Start date	7 March 2023
Primary completion	22 February 2024
Estimated completion	22 February 2024
Sites	1 location across Mexico

Drugs / interventions tested

Canalicular occlusion device

Conditions studied

Dry Eye — all drugs for Dry Eye →

Sponsor

AesculaTech, Inc.

Who can join

22 and older, any sex, with Dry Eye. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Participants will receive a tear duct plug to see if their eye comfort improves.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Dry Eye

Currently open trials in the same condition.

NCT07366944 — PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes · NA · recruiting
NCT07329712 — Comparing Tear Proteomics Profile in Dry Eye Disease pre-and Post-treatment With Low Level Light Therapy · recruiting
NCT07266948 — Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work · Phase 4 · recruiting
NCT07298811 — Preliminary Clinical Study of the Effectiveness and Safety of Ocular Surface Microbiota Transplantation in the Treatment · Phase 1, PHASE2 · recruiting
NCT07135193 — Evaluation of the Protective Effects of Cordyceps Cicadae on Visual Function and Anti-Fatigue Performance in Esports Ath · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05748951 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by AesculaTech, Inc.
Last refreshed: 30 July 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05748951.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing